SCHEMBL30976646

SCHEMBL30976646

CC(=O)O[C@H]1[C@H](OC(=O)c2ccccc2)[C@H](COC(=O)c2ccccc2)O[C@@H]1n1cc(C)c(=O)[nH]c1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.60
▸ USP2 O75604 1/20 0.60
▸ POLB P06746 1/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ RNASE1 P07998 1/20 0.54
▸ GAPDH P04406 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.49
▸ HTT P42858 1/20 0.49
▸ LMNA P02545 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ TK1 P04183 1/20 0.45
▸ TK2 O00142 2/20 0.44
▸ TYMP P19971 1/20 0.43
▸ HRAS P01112 1/20 0.42
▸ TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8591286 0.96 MEN1 (0.61) MEN1USP2POLBKMT2ARNASE1
SCHEMBL5983740 0.96 MEN1 (0.61) MEN1USP2POLBKMT2ARNASE1
SCHEMBL1882384 0.96 MEN1 (0.61) MEN1USP2POLBKMT2ARNASE1
SCHEMBL9223575 0.96 MEN1 (0.61) MEN1USP2POLBKMT2ARNASE1
SCHEMBL21886712 0.96 MEN1 (0.61) MEN1USP2POLBKMT2ARNASE1
SCHEMBL14428953 0.95 MEN1 (0.60) MEN1USP2POLBKMT2ARNASE1
SCHEMBL16907939 0.92 MEN1 (0.56) MEN1USP2POLBKMT2ARNASE1
SCHEMBL19132202 0.92 MEN1 (0.56) MEN1USP2POLBKMT2ARNASE1
SCHEMBL9131765 0.92 MEN1 (0.56) MEN1USP2POLBKMT2ARNASE1
SCHEMBL15691494 0.92 MEN1 (0.56) MEN1USP2POLBKMT2ARNASE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024107850-A1 HALO-DEHYDRO-3'-DEOXYURACIL PHOSPHORAMIDATES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS ROME THERAPEUTICS, INC. (US) 2024-05-23 — — WO disclosed
Send feedback